
Psychology
Safety and Tolerability of the Acute Ketamine Treatment in Treatment-Resistant Depression: Focus on Comorbidities Interplay with Dissociation and Psychomimetic Symptoms
A. Włodarczyk, A. Dywel, et al.
This groundbreaking study by Adam Włodarczyk, Alicja Dywel, and Wiesław Jerzy Cubała explores the safety of intravenous ketamine for treatment-resistant depression in patients with major depressive disorder and bipolar depression. It uncovers significant findings related to epilepsy and the effects of comorbidities, emphasizing the need for vigilant clinical supervision during treatment.
Playback language: English
Related Publications
Explore these studies to deepen your understanding of the subject.